In an effort to give you the best possible service, we would be grateful if you could take a few minutes of your time to answer a few questions.
Last month, the federal government announced that Medicare has broadened its guidelines to cover USFDA-approved or -cleared genetic testing for ovarian and breast cancer patients. Genetic testing (or Next Generation Sequencing as a diagnostic laboratory test) provides the most comprehensive genetic analysis of a patient’s cancer because it enables simultaneous detection of multiple types of genetic alterations. Now more Medicare patients will have access to these tests for managing other types of inherited cancers and to reduce mortality and improve health outcomes.
“Medicare has realized that genetics is transforming medicine,” said Georgia CORE’s oncology clinical nurse specialist, Alice Kerber. “Genetic testing provides valuable information to guide patients and physicians in developing a personalized treatment plan.”
More information is at cms.gov.
Last week, the American Society of Clinical Oncology (ASCO) launched the ASCO Survey on COVID-19 in Oncology Registry.
The CDC-funded program will bring colorectal screening, navigation and colonoscopies to 15,000 people in southeast and southwest Georgia.
Georgia CORE's Dr. Hamrick breaks down national data on how COVID-19 has been impacting cancer care in Georgia.
Media & Events
Nearly 400 volunteers in 58 counties have been cutting out fabric and elastic, handling administrative duties and of course, sewing.
Our email newsletter allows you to get the most up-to-date information right in your Inbox.
Advancing Cancer Care through Partnerships and Innovation
Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.